• Argan, Inc. recently announced that its subsidiary Gemma Power Systems received full notice to proceed on an EPC contract for the 1,350 MW CPV Basin Ranch Energy Center in Texas, with construction slated through 2028 and possible carbon capture integration.
• This project both highlights Argan's ability to secure large-scale, advanced power infrastructure work and reinforces its presence in projects designed for cleaner energy solutions.
• We'll explore how this major contract award strengthens Argan's multi-year backlog and underpins its outlook for sustained revenue growth.

These 15 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.

Argan Investment Narrative Recap

For those considering Argan, the big picture is a company with a track record of delivering large-scale power projects, supported by robust secular tailwinds in North American infrastructure investment. The recent Texas EPC contract meaningfully boosts Argan’s multi-year project backlog, providing greater visibility for near-term revenue, though the primary risk remains exposure to project execution given the company’s reliance on a small number of complex builds. In the short term, the announcement addresses the most immediate earnings catalyst, backlog growth, but does not eliminate the inherent variability tied to individual project performance.

The most relevant recent announcement is Argan’s 33% dividend increase in September 2025. This move underscores confidence in future cash flow generation, supported by major contract wins like CPV Basin Ranch, and highlights management’s ongoing commitment to returning value to shareholders. Sustained dividend growth, together with growing backlog, continues to be a significant catalyst that could support shareholder returns, even as project execution and margin variability remain risks to monitor.

However, investors should also be aware that despite the record backlog and these contract awards, the company’s earnings remain heavily exposed to...

Argan's outlook anticipates $1.5 billion in revenue and $142.0 million in earnings by 2028. This reflects an 18.1% annual revenue growth and a $24.8 million earnings increase from the current $117.2 million.

Uncover how Argan's forecasts yield a $262.00 fair value, a 14% downside to its current price.

Exploring Other Perspectives

Eight Simply Wall St Community members place Argan’s fair value between US$229.49 and US$284.68 per share. While many look to project backlog as a growth engine, project execution risk continues to be front-of-mind for those tracking Argan’s performance.

Explore 8 other fair value estimates on Argan - why the stock might be worth 25% less than the current price!

Build Your Own Argan Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your Argan research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Argan research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Argan's overall financial health at a glance.

Ready For A Different Approach?

These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

• Uncover the next big thing with financially sound penny stocks that balance risk and reward.
• AI is about to change healthcare. These 33 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Outshine the giants: these 26 early-stage AI stocks could fund your retirement.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.